Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Retained Earnings (2020 - 2026)

PROCEPT BioRobotics has reported Retained Earnings over the past 7 years, most recently at -$673.2 million for Q1 2026.

  • Quarterly Retained Earnings fell 17.95% to -$673.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$673.2 million through Mar 2026, down 17.95% year-over-year, with the annual reading at $37000.0 for FY2025, 100.01% up from the prior year.
  • Retained Earnings was -$673.2 million for Q1 2026 at PROCEPT BioRobotics, down from $37000.0 in the prior quarter.
  • Over five years, Retained Earnings peaked at $217000.0 in Q3 2022 and troughed at -$673.2 million in Q1 2026.
  • The 5-year median for Retained Earnings is -$402.4 million (2023), against an average of -$310.2 million.
  • Year-over-year, Retained Earnings tumbled 7576100.0% in 2023 and then soared 653.33% in 2024.
  • A 5-year view of Retained Earnings shows it stood at -$6000.0 in 2022, then tumbled by 7576100.0% to -$454.6 million in 2023, then dropped by 20.11% to -$546.0 million in 2024, then skyrocketed by 100.01% to $37000.0 in 2025, then crashed by 1819545.95% to -$673.2 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Retained Earnings are -$673.2 million (Q1 2026), $37000.0 (Q4 2025), and $42000.0 (Q3 2025).